Antisense Therapeutics Limited (Issuer Code: ANP) Non-Renounceable Issue not displayed in Daily Diary
In the Daily Diary published on 30 November 2016, a Non Renounceable Corporate action for Antisense Therapeutics Limited (ASX: ANPO) was not displayed.
The details of this Non Renounceable are as follows;
Eligible Option holders may apply for one (1) New Option for every one (1) ANPO Option held on the Record Date. The issue price for New Options is $0.002. A New Option entitles the holder to exercise the New Option for a Share for a price of $0.08. The holder may exercise the New Option at any time prior to 5:00pm on the New Option Expiry Date of 19 December 2019.
Daily Diary customers are to note that the Daily Diary published on 30 November 2016 did not contain the information on the Non-Renounceable Issue.
For reference, below is the re-created Daily Diary section that was not published;
NON RENOUNCEABLE ISSUE |
|
Full Company Name |
ANTISENSE THERAPEUTICS LIMITED |
Entered Date |
30-NOV-2016 |
Accelerated Offer |
Not accelerated |
Ex-Date |
02-DEC-2016 |
Record Date |
05-DEC-2016 |
Applications Close Date |
15-DEC-2016 |
New Securities Deferred Trading Date |
16-DEC-2016 |
Issue Date New Securities |
19-DEC-2016 |
Type of Corporate Action |
Non Renounceable (Primary) |
ASX Code (Subject) |
ANPO |
ASX Code (Object) |
ANPOC |
Security Type to be Issued |
OPTIONS |
Offer Ratio Multiplier (New Object) |
1 |
Offer Ratio Divisor (For every Subject) |
1 |
Fractional entitlements |
2 - Fractions disregarded / rounded down |
Application Capital/Price Data |
$0.002 |
Maximum Number of Securities to be |
46950985 |
Ranking with existing securities |
|
Cash Adjustment |
$0.01 |
Upcoming Events
Date |
Event |
Bulletin/Notice No. |
TBA |
Change to the ASX BookBuild (BB) ASX coding convention and security description. |
24/15, 29/15 |
TBA |
Proposed changes to ISIN structure. |
43/13, 01/14, 45/14 |
TBA |
Increase from 10 to 20 in number of ASX ComNews™ Report Type Codes able to be disseminated for a single Market Announcement. |
45/14, 47/14, 50/14, 51/14, 55/14
|
TBA |
Introduction of new intra-day Dividend corporate action product. |
55/13, 06/14, 18/14, 43/14 |
TBA
|
Introduction of six (6) S&P/ASX real time fixed income indices. Introduction of additional fifteen (15) S&P/ASX real time fixed income indices. |
29/13 42/13 |
TBA |
Removal of SP & SQ messages from ReferencePoint Master List E01 and E02 files. |
02/12, 06/12, 08/12, 22/12, 35/12, 37/12, 04/13, 46/13, 48/13, 02/14, 05/14, 06/14, 18/14 |
TBA |
Daily availability of ReferencePoint Master List E20 file – SP & SQ messages security details full download. E20 CSV file format change to be in line with all the ReferencePoint Master List CSV files. |
02/14, 05/14, 06/14, 18/14 18/14, 23/14, 24/14 |
Daily Diary customers are requested to update their own systems with the details provided in this Notice regarding the ANPO Non-Renounceable entitlement issue offer.
Edwina Glinoga, Trading Services – Market Data
Customer Technical Support
+61 (02) 9227 0372
CTS@asx.com.au